Effect of Cyanoacrylate Tissue Adhesive Versus Collagen Sponge on Palatal Donor Site Healing
Launched by BEIRUT ARAB UNIVERSITY · Jul 24, 2025
Trial Information
Current as of October 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well a special medical glue called PeriAcryl helps heal the roof of the mouth (palate) after a small piece of tissue is taken for gum surgery. The researchers want to see if using PeriAcryl helps the tissue heal faster and if patients feel better about their healing compared to using a collagen sponge, which is another common treatment.
Adults between 18 and 74 years old who need this type of gum surgery and are generally healthy may be able to join. To be eligible, participants should not have serious health problems, should not smoke heavily, and should have good oral hygiene. During the study, participants will be randomly assigned to receive either the PeriAcryl glue or the collagen sponge on the wound site. The researchers will then follow up to check how well the area heals and how satisfied patients feel about their recovery. This trial is currently looking for volunteers and aims to find better ways to support healing after gum surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Low-moderate anesthetic risk (ASA I-II)
- • No restriction on ethnicity or gender
- • Patients requiring FGG from the palate for periodontal plastic surgery
- • Clinically healthy gingiva after phase I therapy
- • Full-mouth plaque index grades 0 and 1
- • Bleeding scores \<15%
- Exclusion Criteria:
- • Patients who smoke \> 10 cigarettes/day
- • Patients with coagulation disorders
- • Systemic diseases
- • Patients on certain medications that may affect periodontal tissues
- • Pregnant and lactating patient
- • Patients with allergies to drugs that will be prescribed during the treatment phase
- • Pathological mental conditions (dementia, psychosis) and lack of cooperation
- • Excessive gag reflex
About Beirut Arab University
Beirut Arab University (BAU) is a distinguished educational institution in Lebanon, committed to advancing healthcare through rigorous research and innovative clinical trials. As a clinical trial sponsor, BAU leverages its academic expertise and collaborative networks to facilitate groundbreaking studies that aim to enhance patient outcomes and contribute to the broader medical community. The university's multidisciplinary approach fosters an environment of excellence, ensuring adherence to ethical standards and regulatory compliance while promoting scientific discovery and the translation of research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beirut, Lebanon
Patients applied
Trial Officials
Nayer Aboelsaad
Study Chair
Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported